Targeting the EphA2 pathway: could it be the way for bone sarcomas?
Abstract Bone sarcomas are malignant tumors of mesenchymal origin. Complete surgical resection is the cornerstone of multidisciplinary treatment. However, advanced, unresectable forms remain incurable. A crucial step towards addressing this challenge involves comprehending the molecular mechanisms u...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2024-09-01
|
| Серии: | Cell Communication and Signaling |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s12964-024-01811-7 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|